Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing
Reexamination Certificate
2005-11-01
2005-11-01
Spector, Lorraine (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C514S002600, C435S007200, C435S007210, C436S501000, C530S350000, C530S351000
Reexamination Certificate
active
06960558
ABSTRACT:
The present invention relates to methods for screening for anti-obesity agents using the ciliary neutrophic factor receptor.
REFERENCES:
patent: 4997929 (1991-03-01), Collins et al.
patent: 5011914 (1991-04-01), Collins et al.
patent: 5141856 (1992-08-01), Collins et al.
patent: 5166317 (1992-11-01), Wallace et al.
patent: 5349056 (1994-09-01), Panayotatos
patent: 5426177 (1995-06-01), Davis et al.
patent: 5441937 (1995-08-01), Wallace et al.
patent: 5470952 (1995-11-01), Stahl et al.
patent: 5593857 (1997-01-01), Higaki et al.
patent: 5648334 (1997-07-01), Davis et al.
patent: 5691313 (1997-11-01), Russell
patent: 5780600 (1998-07-01), Collins et al.
patent: 5846935 (1998-12-01), Panayotatos
patent: 5849897 (1998-12-01), Davis et al.
patent: 5892003 (1999-04-01), Davis et al.
patent: 5955290 (1999-09-01), Stahl et al.
patent: 6143714 (2000-11-01), Wong et al.
patent: 6565869 (2003-05-01), Ciliberto et al.
patent: WO 91/04316 (1991-04-01), None
patent: WO 93/02206 (1993-02-01), None
patent: WO 93/10233 (1993-05-01), None
patent: WO 94/09134 (1994-04-01), None
Di Marco, A. et al. “Identification of ciliary neurotrophic factor (CNTF) residues essential for leukemia inhibitory factor receptor binding and generation of CNTF receptor antagonists”, Proc. Natl. Acad. Sci. USA. 1996, vol. 93, pp. 9247-9252.
Saggio, I. J. et al. “CNTF variants with increased biological potency and receptor selectivity define a functional site of receptor interaction”, The EMBO Journal, 1995, vol. 14, pp. 3045-3054.
Fantuzzi, G. et al. “Ciliary neurotrophic factor (CNTF) induces serum amyloid A, hypoglycaemia and anorexia, and potentiates IL-I induced corticosterone and IL-6 production in mice”, Cytokine, 1955, vol. 7, pp. 150-156.
Sarraf, P. et al. “Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia”, The Journal of Experimental Medicine, 1997, vol. 185, pp. 171-175.
Gloaguen, I. et al. “Ciliary neurotrophic factor corrects obesity and diabetes associated with Leptin deficiency and resistance”, Proc. Natl. Acad. Sci. USA, 1997, vol. 94, pp. 6456-6461.
Poduslo, J. et al. “Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF”, Molecular Brain Research, 1996, vol. 36, pp. 280-286.
ALS CNTF Treatment Study Group, “A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis”, Neurology, 1996, vol. 46, pp. 1244-1249.
Miller, R. et al. “A Placebo-controlled Trial of Recombinant Human Ciliary Neurotrophic (rhCNTF) Factor in Amyotrophic Lateral Sclerosis”, Ann. Neurol., 1996, vol. 39, pp. 256-260.
Halaas, J. et al. “Weight-Reducing Effects of the Plasma Protein Encoded by theobeseGene”, Science, 1995, vol. 269, pp. 543-546.
Pelleymounter, M. et al. “Effects of theobeseGene Product on Body Weight Regulation inoblobMice”, Science, 1995, vol. 269, pp. 540-543.
Henderson, J. et al. “Systemic Administration of Ciliary Neurotrophic Factor Induces Cachexia in Rodents”, J. Clin. Invest., 1994, vol. 93, pp. 2632-2638.
Panayotatos, N. et al. “Exchange of a Single Amino Acid Interconverts the Specific Activity and Gel Mobility of Human and Rat Ciliary Neurotrophic Factors”, The Journal of Biological Chemistry, 1993, vol. 268, pp. 19000-19003.
Ciliberto Gennaro
Cortese Riccardo
Demartis Anna
Di Marco Annalise
Gloaguen Isabelle
Heber Sheldon O.
Instituto di Recerche di Biologia Molecolare P. Angeletti S.p.A.
O'Hara Eileen B.
Spector Lorraine
Tribble Jack L.
LandOfFree
Method of screening for anti-obesity agents using ciliary... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of screening for anti-obesity agents using ciliary..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of screening for anti-obesity agents using ciliary... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3521944